Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
11/1999
11/09/1999US5981535 Substituted xanthines and their use in the treatment of cerebrovascular disorders and other diseases
11/09/1999US5981506 Method for treating sinusitis with uridine triphosphates and related compounds
11/09/1999US5981483 Compositions comprising modulators of cytokines of the TGF-β superfamily
11/09/1999US5981275 Plasmid comprising heterologous genes linked to cytomegalo virus promoters and stably produces heterologous gene product; for delivery to cells
11/09/1999US5980865 Administering to the patient of a pharmaceutical composition containing about 0.005 to about 1.0 mg of ultra-low molecular weight heparins
11/09/1999CA2102321C Partial liquid breathing of fluorocarbons
11/04/1999WO1999055734A1 A g-protein coupled 7tm receptor (axor-1)
11/04/1999WO1999055733A1 Cloning of a novel 7tm receptor axor-2
11/04/1999WO1999055696A1 New hydroxyindoles, their use as phosphodiesterase 4 inhibitors and method for producing same
11/04/1999WO1999055678A1 Quinoline derivatives
11/04/1999WO1999055663A1 Inhibitors of impdh enzyme
11/04/1999WO1999055388A1 Substituted porphyrins
11/04/1999WO1999055342A1 Therapeutic anti-cold agent containing isomalt as an active ingredient
11/04/1999WO1999055330A1 Ccr-3 receptor antagonists
11/04/1999WO1999055324A1 Ccr-3 receptor antagonists
11/04/1999WO1999055319A1 Aerosol formulations of salmeterol xinafoate
11/04/1999WO1999055312A2 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
11/04/1999DE19818964A1 New hydroxy-indole derivatives useful in treatment of degenerative joint disease, viral and parasitic infections, bronchial, dermatological, neurodegenerative and prostate disorders, etc.
11/04/1999CA2330563A1 Therapeutic anti-cold agent containing isomalt as an active ingredient
11/04/1999CA2329821A1 Ccr-3 receptor antagonists
11/04/1999CA2329777A1 Ccr-3 receptor antagonists
11/03/1999EP0763055B1 Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
11/03/1999CN1234071A Keratinocyte grouth factor -2(KGF-2 or fibroblast growth factor-12, FGF-12)
11/03/1999CN1234039A 3-mercaptoacetylamino-1,5-subsd. 2-oxo-azepon derivatives useful as inhibitor of metrix metalloproteinase
11/03/1999CN1234031A Indazole derivatives and their use as inhibitors of phosphodiesterase (PDE) type IV and the prodn. of tumor necrosis factor (TNF)
11/03/1999CN1234026A Piperazino derivatives as neurokinin antagonists
11/03/1999CN1233960A Chlorofluorocarbon-free mometasone furoate aerosol formulations
11/03/1999CN1233500A Nasal cavity paste for preventing influenza
11/03/1999CN1233496A Traditional Chinese medicinal capsule for treating cough with dyspnea
11/03/1999CN1233494A Infantile plaster for relieving cough
11/02/1999US5977384 Benzothiazolone derivatives
11/02/1999US5977359 Substituted heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present
11/02/1999US5977337 The nucleic acid molecule may be used in the diagnosis of infection.
11/02/1999US5977150 Amino acid derivatives of diaryl 1,3,4-oxadiazolone
11/02/1999US5977135 Bicyclic heterocycles
11/02/1999US5977124 β-adrenergic agonists
11/02/1999US5977122 Antiinflammatory, antiallergens, tumor necorsis factor inhibitor
11/02/1999US5977119 Trisubstituted thioxanthines
11/02/1999US5977108 Leukemia
11/02/1999US5977105 Compounds
11/02/1999US5977103 Substituted imidazole compounds
11/02/1999US5977095 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and respiratory distress syndrome
11/02/1999US5977091 Tetracycline adminsteration
11/02/1999US5977084 Self-assembling polynucleotide delivery method
11/02/1999US5977075 N-aroylamino acid amides as endothelin inhibitors
11/02/1999US5976834 cDNA clone HNFJD15 that encodes a novel human 7-transmembrane receptor
11/02/1999US5976576 Active material is n-4-(1h-tetrazol-5-yl)phenyl-4-(1h-tetrazol-5-yl)benzamide, disodium salt
11/02/1999US5976573 Aqueous-based pharmaceutical composition
11/02/1999CA2160689C New method of treatment
10/1999
10/28/1999WO1999054469A1 B-cell growth factor related protein
10/28/1999WO1999054351A1 Edg family gene, human h218
10/28/1999WO1999054333A1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
10/28/1999WO1999054331A1 Novel asymmetrically substituted xanthine derivatives, method for producing them and their use as medicaments with an adenosine-antagonistic effect
10/28/1999WO1999054284A1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
10/28/1999WO1999053935A1 Novel synergistic compositions containing aromatic compounds and terpenoids present in alpinia galanga
10/28/1999WO1999053926A1 Use of a glucocorticosteroid for the manufacture of a medicament for treating mild/early forms of copd (chronic obstructive pulmonary disease)
10/28/1999WO1999053901A1 Pharmaceutical aerosol formulation
10/28/1999CA2329008A1 Use of a glucocorticosteroid for the manufacture of a medicament for treating mild/early forms of copd (chronic obstructive pulmonary disease)
10/28/1999CA2328882A1 Pharmaceutical aerosol formulation
10/28/1999CA2328413A1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
10/28/1999CA2328264A1 Novel asymmetrically substituted xanthine derivatives, method for producing them and their use as medicaments with an adenosine-antagonistic effect
10/28/1999CA2325848A1 B-cell growth factor related protein
10/27/1999EP0952149A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors
10/27/1999EP0951556A2 Disease associated protein tyrosine phosphatases
10/27/1999EP0951292A1 Methods for treating an ischemic disorder and improving stroke outcome
10/27/1999EP0951279A1 Tablet for the controlled release of active agents
10/27/1999CN1233256A Dipeptide benzamidine as a kininogenase inhibitor
10/27/1999CN1233254A Purine L-nucleosides, analogs and uses thereof
10/27/1999CN1233238A Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists
10/27/1999CN1233189A Treatment of asthma with TNFR-Ig
10/27/1999CN1233181A Method of treating ciliary dyskinesia with uridine triphosphates and related compounds
10/27/1999CN1233179A Treatment of upper airway allergic responses with a combination of histamine receptor antagonists
10/27/1999CN1233177A Therapeutic treatment for VEGF related diseases
10/27/1999CN1233176A Substituted tricyclics
10/27/1999CN1232701A Process for preparing herbal compositions for treatment of bronchitis and respiratory disorders with anticancer properties
10/27/1999CN1232673A Chinese herbal decoction as oral liquid and its preparation and application
10/26/1999US5973167 Sulfonamide group, ether containing acid
10/26/1999US5973009 Antioxidant and cytoprotecting activity
10/26/1999US5972988 Method for treatment of chronic bronchitis using indole compounds
10/26/1999US5972972 Pyrazoles as human non-pancreatic secretory phospholipase A2 inhibitors
10/26/1999US5972961 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators
10/26/1999US5972940 Arginine analogues having nitric oxide synthase inhibitor activity
10/26/1999US5972936 Benzofuran carboxamides and their therapeutic use
10/26/1999US5972927 Antiinflammatory, antiallergic and bronchodilatory medicinal products, treatment of asthma
10/26/1999US5972919 Combination of a bronchodilator and a steroidal anti-inflammatory drug for the treatment of respiratory disorders, as well as its use and the preparation thereof
10/26/1999US5972904 Method of treating sinusitis with uridine triphosphates and related compounds
10/26/1999US5972897 Acylated enol derivatives as prodrugs of elastase inhibitors
10/26/1999US5972894 Peptides having potassium channel opener activity
10/26/1999US5972698 Tryptase is expressed virtually exclusively by mast cells.
10/26/1999US5972652 Polynucleotides encoding secreted proteins
10/26/1999US5972651 Polynucleotides and polypeptides of the fifty-four homologue family, (ffh); vectors and transformed host cells; ffh are components of protein secretory apparatus and their inhibition of function is deleterious to bacteria cells
10/26/1999US5972606 A polypeptide; treating osteoporosis, eating disorders, brain disorders, adult respiratory disease syndrome, huntington'sdisease, ulcers, cardiovascular disorders, parkinson's disease;
10/21/1999WO1999052910A1 Bicyclic hydroxamic acid derivatives
10/21/1999WO1999052903A1 Prodrugs of benzofuranylmethyl carbamate nk1 antagonists
10/21/1999WO1999052898A1 N,n-disubstituted amides that inhibit the binding of integrins to their receptors
10/21/1999WO1999052889A1 (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides
10/21/1999WO1999052862A1 Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors
10/21/1999WO1999052848A1 Phosphodiesterase isoenzyme denominated 4 (pde 4) inhibiting compounds
10/21/1999WO1999052847A1 Phosphodiesterase isoenzyme denominated 4 (pde 4) inhibiting compounds
10/21/1999WO1999052555A1 Methods and compositions using norastemizole in combination with leukotriene inhibitors
1 ... 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 ... 878